29th Annual Mount Sinai Winter Symposium - Advances in Medical, Surgical and Cosmetic Dermatology

Friday, December 4, 2026, 6:30 AM - Sunday, December 6, 2026, 3:00 PM, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY


This unique and dynamic symposium, sponsored by the Dermatology Department of the Icahn School of Medicine a Mount Sinai in New York City, will take place Thursday, December 3rd (Pre-Symposium) through Sunday, December 6th at the New York Academy of Medicine located at 1216 Fifth Avenue, New York, NY 10029. We anticipate having in attendance 550 physicians and health professionals from across the United States and internationally. The educational program will be comprised of comprehensive presentations delivered by the world-renowned speakers and experts in the dermatology field.

1. Evaluate emerging evidence and landmark studies in medical, surgical, cosmetic dermatology, and dermatopathology and incorporate relevant findings into clinical practice
2. Apply current evidence-based diagnostic and therapeutic strategies for medical dermatological conditions, including alopecia areata, psoriasis, eczema, actinic keratosis, rosacea, and skin cancer
3. Compare contemporary surgical techniques, including closure methods and cosmetic procedures, and intergrate appropriate approaches into clinical practice
4. Assess new cosmetic agents, including fillers and neurotoxins, and apply evidence-based injection techniques to enhance procedural safety and treatment outcomes
5. Evaluate live patient demonstrations utilizing approved technologies for the treatment of photodamage and age-related skin changes and identify techniques that optimize procedural planning and patient selection
6. Differentiate the clinical presentation and management considerations of psoriasis, eczema, and dermatitis to support accurate diagnosis and treatment selection
7. Apply updated guideline recommendations and evidence-based management strategies for patients with actinic keratosis
8. Incorporate emerging therapies and evolving treatment paradigms for vitiligo and cutaneous lymphomas into patient care planning
9. Assess the epidemiology, associated risk factors, and clinical implications of alopecia areata to support earlier diagnosis and individualized management strategies

Physicians (3 DAYS)	$550.00
Physicians (Friday and Saturday 2 Days)	$350.00
Physicians (Friday or Saturday or Sunday 1 Day)	$325.00
PA's, NP's and RN's	$350.00
Mount Sinai Health System	$300.00
Residents*/Fellows*/Medical Students*	$0*
Industry Reps and Non Physicians	$400.00

 
* Complimentary attendance with a letter from you program director or copy of hospital ID. Proof must be emailed to [email protected]

Cancellation Policy
All refund and cancellation requests must be emailed to the CME office at [email protected] by November 19, 2026. Cancellations after this date are not eligible for a refund. An administrative fee of $50 will be deducted from your refund. No refunds will be issued for registration fees that are equal to or less than $50.00. No refunds will be issued for “no-shows.”

Parking
The entrance to the Mount Sinai Parking Garage is located on the SW corner of 99th Street and Park Avenue. Discounted Parking is available for Saturday and Sunday only. Parking ticket will be validated at the Registration

Meeting Location
The New York Academy of Medicine
1216 Fifth Avenue (at 103rd Street)
New York, NY 10029

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (15.50 hours), Non-Physician Attendance (15.50 hours)

If you would like assistance with hotel arrangements, please contact our Housing Manager, Denise Newman by email: [email protected] or call 347-236-7181.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all accredited CE educational activities. All individuals in control of content of an activity accredited by ISMMS are expected to disclose all their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place.